Regular access to safe, affordable and effective medicines is integral to improving patient outcomes. But in the European Union (EU), ever-increasing medicine prices, combined with shrinking healthcare budgets, are jeopardising the potential for patients to access treatment when they need it. At the same time, pharmaceutical promotion continues to surround healthcare professionals throughout the EU, potentially undermining patient safety and the sustainability of healthcare systems.
Mājaslapas jaunā versija tapusi pateicoties Latvijas valsts budžeta finansētai programmai "NVO Fonds". Projektu finansiāli atbalsta Sabiedrības integrācijas fonds no Latvijas valsts budžeta līdzekļiem.